Amalgamated Bank Ginkgo Bioworks Holdings, Inc. Transaction History

Amalgamated Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.06 - $1.67 $148,813 - $234,451	-140,390 Reduced 61.06%	89,525 $104,000
Q4 2023 Feb 06, 2024	SELL	$1.26 - $1.79 $18,108 - $25,725	-14,372 Reduced 5.88%	229,915 $389,000
Q3 2023 Nov 08, 2023	BUY	$1.61 - $2.54 $53,107 - $83,784	32,986 Added 15.61%	244,287 $442,000
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.95 $65,695 - $112,374	57,628 Added 37.5%	211,301 $393,000
Q1 2023 May 02, 2023	SELL	$1.2 - $2.19 $19,257 - $35,145	-16,048 Reduced 9.46%	153,673 $204,000
Q4 2022 Feb 10, 2023	BUY	$1.63 - $3.52 $22,145 - $47,822	13,586 Added 8.7%	169,721 $287,000
Q3 2022 Nov 09, 2022	BUY	$0.73 - $3.74 $1,011 - $5,183	1,386 Added 0.9%	156,135 $487,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $340,447 - $649,945	154,749 New	154,749 $368,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $11.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.